Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07430423 · ClinicalTrials.gov registry record
The FLOW Registry.
A clinical trial, sponsored by University of Chicago.
- Not yet
- Registry status
- 3,000
- Enrollment target
NCT07430423 is a clinical trial that has not yet begun recruiting, run by University of Chicago. The registered enrollment target is 3,000 participants.
The verdict
NCT07430423 has not yet begun recruiting, sponsored by University of Chicago.
- NOT YET RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
Study Summary
The purpose of this study is to create a database and prospective registry for data collection on patients with benign prostatic hyperplasia undergoing Aquablation of the prostate. All patients undergoing Aquablation of the prostate will be enrolled in the registry. Historical data from 1/1/2024- 11/30/2025 will be added through chart review. Current and future patient data will be collected through chart review during the subject's clinical care. Only data available in the electronic medical record will be collected and no additional data will be collected for research purposes. No biospecimens will be collected, and there are no physical risks from study participation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2026-08 |
| Est. Completion | 2036-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07430423
The ClinicalTrials.gov registry entry for NCT07430423 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07430423 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07430423 about?
NCT07430423 is a clinical study titled "The FLOW Registry.". The purpose of this study is to create a database and prospective registry for data collection on patients with benign prostatic hyperplasia undergoing Aquablation of the prostate. All patients undergoing Aquablation of the prostate will be enrolled in the registry. Historical data from 1/1/2024- 11...
What is the current status of trial NCT07430423?
This trial is currently not yet recruiting. The enrollment target is 3,000 participants. The study started on 2026-08. Estimated completion is 2036-12.
Who is sponsoring clinical trial NCT07430423?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.